远大医药集团有限公司（00512）于2026年3月2日披露的月报表显示，截至2026年2月28日，公司已发行股份总数为3,549,571,148股，较上月底维持不变。报告期内，公司法定/注册股本仍为100,000,000,000股（面值每股0.01港元），对应法定/注册股本总额10亿港元，未见增减变动。
公告称，当月无新增发行、购回、注销或库藏股份，亦未涉及任何股份期权、权证或可换股票据的行使或变动。截至本月底，公司确认继续符合香港联交所规定的公众持股量要求，股本结构保持稳定。
公司进一步确认，本报告期内所有涉及股份发行或库藏股份的事宜均已获得董事会正式授权，并严格遵守适用的上市规则及相关法律规定。公告由公司秘书傅天忠签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.